@article{MTMT:34760650,
	title = {Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedema},
	url = {https://m2.mtmt.hu/api/publication/34760650},
	author = {Knobler, R. and Geroldinger-Simić, M. and Kreuter, A. and Hunzelmann, N. and Moinzadeh, P. and Rongioletti, F. and Denton, C. and Mouthon, L. and Cutolo, M. and Smith, V. and Gabrielli, A. and Bagot, M. and Olesen, A.B. and Foeldvari, I. and Jalili, A. and Kähäri, V.M. and Kárpáti, Sarolta and Kofoed, K. and Olszewska, M. and Panelius, J. and Quaglino, P. and Seneschal, J. and Sticherling, M. and Sunderkötter, C. and Tanew, A. and Wolf, P. and Worm, M. and Skrok, A. and Rudnicka, L. and Krieg, T.},
	doi = {10.1111/jdv.19937},
	journal-iso = {J EUR ACAD DERMATOL},
	journal = {JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY},
	unique-id = {34760650},
	issn = {0926-9959},
	year = {2024},
	eissn = {1468-3083},
	orcid-numbers = {Kárpáti, Sarolta/0000-0002-8472-0712}
}

@article{MTMT:34760626,
	title = {Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes},
	url = {https://m2.mtmt.hu/api/publication/34760626},
	author = {Knobler, R. and Geroldinger-Simić, M. and Kreuter, A. and Hunzelmann, N. and Moinzadeh, P. and Rongioletti, F. and Denton, C.P. and Mouthon, L. and Cutolo, M. and Smith, V. and Gabrielli, A. and Bagot, M. and Olesen, A.B. and Foeldvari, I. and Jalili, A. and Kähäri, V. and Kárpáti, Sarolta and Kofoed, K. and Olszewska, M. and Panelius, J. and Quaglino, P. and Seneschal, J. and Sticherling, M. and Sunderkötter, C. and Tanew, A. and Wolf, P. and Worm, M. and Skrok, A. and Rudnicka, L. and Krieg, T.},
	doi = {10.1111/jdv.19912},
	journal-iso = {J EUR ACAD DERMATOL},
	journal = {JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY},
	unique-id = {34760626},
	issn = {0926-9959},
	year = {2024},
	eissn = {1468-3083},
	orcid-numbers = {Kárpáti, Sarolta/0000-0002-8472-0712}
}

@article{MTMT:34765365,
	title = {Cutaneous leishmaniosis in childhood},
	url = {https://m2.mtmt.hu/api/publication/34765365},
	author = {Kárpáti, Sarolta},
	doi = {10.7188/bvsz.2023.99.1.10},
	journal-iso = {BVSZ},
	journal = {BŐRGYÓGYÁSZATI ÉS VENEROLÓGIAI SZEMLE},
	volume = {99},
	unique-id = {34765365},
	issn = {0006-7768},
	abstract = {Clinical symptoms and dermoscopic features of an early cutaneous leishmaniosis diagnosed in a 5-year-old girl are presented. The symptoms started 5-6 months ago, following an earlier short visit to the Middle-East. The report also summarizes the diagnosis, dermatoscopic features and the treatment of this cutaneous parasitosis in children.},
	year = {2023},
	eissn = {2064-261X},
	pages = {79-82},
	orcid-numbers = {Kárpáti, Sarolta/0000-0002-8472-0712}
}

@article{MTMT:34546604,
	title = {Differences in the detection of circulating Hsp90 alpha between patients with atopic dermatitis and dermatitis herpetiformis},
	url = {https://m2.mtmt.hu/api/publication/34546604},
	author = {Sitko, K. and Kárpáti, Sarolta and Węgrzyn, G. and Mincewicz, G. and Trzeciak, M. and Kasperkiewicz, M. and Tukaj, S.},
	doi = {10.3389/fmed.2023.1327144},
	journal-iso = {FRONT MED},
	journal = {FRONTIERS IN MEDICINE},
	volume = {10},
	unique-id = {34546604},
	year = {2023},
	eissn = {2296-858X},
	orcid-numbers = {Kárpáti, Sarolta/0000-0002-8472-0712}
}

@article{MTMT:34217782,
	title = {Az I-es típusú interferon lehetséges szerepe a bőrmelanóma genomikai progressziójában},
	url = {https://m2.mtmt.hu/api/publication/34217782},
	author = {Vízkeleti, Laura and Ladányi, Andrea and Papp, Orsolya and Doma, Viktória and Kárpáti, Sarolta and Rásó, Erzsébet and Barbai, Tamás and Tímár, József},
	journal-iso = {MAGYAR ONKOLÓGIA},
	journal = {MAGYAR ONKOLÓGIA},
	volume = {67},
	unique-id = {34217782},
	issn = {0025-0244},
	year = {2023},
	eissn = {2060-0399},
	pages = {215-221},
	orcid-numbers = {Vízkeleti, Laura/0000-0001-6870-3499; Ladányi, Andrea/0000-0001-9304-8473; Kárpáti, Sarolta/0000-0002-8472-0712; Rásó, Erzsébet/0000-0002-4589-5771; Barbai, Tamás/0000-0002-2374-6097; Tímár, József/0000-0001-9183-0859}
}

@article{MTMT:34110644,
	title = {Targeting Melanoma-Associated Fibroblasts (MAFs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model},
	url = {https://m2.mtmt.hu/api/publication/34110644},
	author = {Hajdara, Anna and Cakir, Ugur and Molnár-Érsek, Barbara and Silló, Pálma and Széky, Balázs and Barna, Gábor and Faqi, Shaaban and Gyöngy, Miklós and Kárpáti, Sarolta and Németh, Krisztián and Mayer, Balázs},
	doi = {10.3390/ijms241612893},
	journal-iso = {INT J MOL SCI},
	journal = {INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES},
	volume = {24},
	unique-id = {34110644},
	issn = {1661-6596},
	abstract = {The tumor microenvironment (TME) has gained considerable scientific attention by playing a role in immunosuppression and tumorigenesis. Besides tumor cells, TME is composed of various other cell types, including cancer-associated fibroblasts (CAFs or MAFs when referring to melanoma-derived CAFs) and tumor-infiltrating lymphocytes (TILs), a subpopulation of which is labeled as γδ T cells. Since the current anti-cancer therapies using γδ T cells in various cancers have exhibited mixed treatment responses, to better understand the γδ T cell biology in melanoma, our research group aimed to investigate whether activated γδ T cells are capable of killing MAFs. To answer this question, we set up an in vitro platform using freshly isolated Vδ2-type γδ T cells and cultured MAFs that were biobanked from our melanoma patients. This study proved that the addition of zoledronic acid (1–2.5 µM) to the γδ T cells was necessary to drive MAFs into apoptosis. The MAF cytotoxicity of γδ T cells was further enhanced by using the stimulatory clone 20.1 of anti-BTN3A1 antibody but was reduced when anti-TCR γδ or anti-BTN2A1 antibodies were used. Since the administration of zoledronic acid is safe and tolerable in humans, our results provide further data for future clinical studies on the treatment of melanoma.},
	year = {2023},
	eissn = {1422-0067},
	orcid-numbers = {Cakir, Ugur/0000-0001-8270-1430; Molnár-Érsek, Barbara/0000-0001-8627-9601; Silló, Pálma/0000-0002-6940-8368; Barna, Gábor/0000-0003-1960-5061; Kárpáti, Sarolta/0000-0002-8472-0712; Mayer, Balázs/0000-0003-3577-3823}
}

@article{MTMT:34027225,
	title = {Cutaneous malignancies in patients with Parkinson’s disease at a dermato-oncological university centre in Hungary},
	url = {https://m2.mtmt.hu/api/publication/34027225},
	author = {Tóth, Veronika and Diakoumakou, S.C. and Kuroli, Enikő and Tóth, Béla and Kuzmanovszki, Daniella and Szakonyi, József and Lőrincz, Kende Kálmán and Somlai, Beáta and Kárpáti, Sarolta and Holló, Péter},
	doi = {10.3389/fonc.2023.1142170},
	journal-iso = {FRONT ONCOL},
	journal = {FRONTIERS IN ONCOLOGY},
	volume = {13},
	unique-id = {34027225},
	issn = {2234-943X},
	year = {2023},
	eissn = {2234-943X},
	orcid-numbers = {Tóth, Veronika/0000-0003-2008-2376; Tóth, Béla/0000-0003-0498-0387; Kuzmanovszki, Daniella/0000-0002-2599-5775; Szakonyi, József/0000-0003-2463-8925; Lőrincz, Kende Kálmán/0000-0002-1861-1008; Kárpáti, Sarolta/0000-0002-8472-0712; Holló, Péter/0000-0002-0744-8989}
}

@article{MTMT:33744801,
	title = {The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries},
	url = {https://m2.mtmt.hu/api/publication/33744801},
	author = {Pipek, Orsolya Anna and Vízkeleti, Laura and Doma, Viktória and Alpár, Donát and Bödör, Csaba and Kárpáti, Sarolta and Tímár, József},
	doi = {10.3390/cancers15061712},
	journal-iso = {CANCERS},
	journal = {CANCERS},
	volume = {15},
	unique-id = {33744801},
	year = {2023},
	eissn = {2072-6694},
	orcid-numbers = {Pipek, Orsolya Anna/0000-0001-8109-0340; Vízkeleti, Laura/0000-0001-6870-3499; Bödör, Csaba/0000-0002-0729-692X; Kárpáti, Sarolta/0000-0002-8472-0712; Tímár, József/0000-0001-9183-0859}
}

@misc{MTMT:33712578,
	title = {Proteogenomic Characterization Reveals Therapeutic Opportunities Related to Mitochondrial Function in Melanoma},
	url = {https://m2.mtmt.hu/api/publication/33712578},
	author = {Jeovanis, Gil and Yonghyo, Kim and Doma, Viktória and Cakir, Ugur and Magdalena, Kuras and Lazaro, Hiram Betancourt and Indira, Pla Parada and Aniel, Sanchez and Yutaka, Sugihara and Roger, Appelqvist and Henriett, Oskolas and Boram, Lee and Jéssica, de Siqueira Guedes and Gustavo, Monnerat and Gabriel, Reis Alves Carneiro and Fábio, CS Nogueira and Gilberto, B. Domont and Johan, Malm and Bo, Baldetorp and Elisabet, Wieslander and István, Balázs Németh and Szász, Attila Marcell and Ho, Jeong Kwon and Runyu, Hong and Krzysztof, Pawłowski and Melinda, Rezeli and József, Tímár and David, Fenyö and Kárpáti, Sarolta and György, Marko-Varga},
	unique-id = {33712578},
	year = {2022},
	orcid-numbers = {Cakir, Ugur/0000-0001-8270-1430; Szász, Attila Marcell/0000-0003-2739-4196; Kárpáti, Sarolta/0000-0002-8472-0712}
}

@CONFERENCE{MTMT:33162598,
	title = {Átvitt HIV gyógyszer-rezisztencia jelentősége a klinikai gyakorlatban},
	url = {https://m2.mtmt.hu/api/publication/33162598},
	author = {Áy, Éva and Adravecz, Lilla and Pocskay, Ágnes and Müller, Viktor and Lakatos, Botond and Szlávik, János and Pék, Tamás and Marschalkó, Márta and Tóth, Béla and Kárpáti, Sarolta and Mezei, Mária and Minárovits, János},
	booktitle = {Magyar Infektológiai és Klinikai Mikrobiológiai Társaság 49. Kongresszusa},
	unique-id = {33162598},
	year = {2022},
	pages = {62-62},
	orcid-numbers = {Pék, Tamás/0000-0001-5189-8656; Kárpáti, Sarolta/0000-0002-8472-0712}
}